Regional Australian First for Lake Imaging
Latest Prostate Cancer Detection Technology to Aid Regional Victorian Men.
Did you know that Prostate cancer is the most common cancer in men?
In August 2016, Lake Imaging St John of God Hospital Ballarat will be the first in regional Australia to host the latest technology service in the fight to detect and optimise outcomes for prostate cancer sufferers.
This new innovative Ga-68 PSMA service will take place on our Ballarat PET CT machine and will aid in the early detection of prostate carcinoma recurrences as well as planning therapies to optimise patient's outcomes.
What exactly is Gallium (Ga-68) PSMA ligand?
A radioactive labelled material that targets specific protein on the surface of the cell membrane. The protein is expressed in high quantity in most types of prostate cancer, allowing detection of early small recurrent /metastatic lesions.
(Ga-68) PSMA ligand is produced in our local lab by highly trained staff.
The lab has been equipped with the latest production and quality assurance equipment to ensure high quality product for ultimate patient safety.
To demonstrate the effectiveness of the Ga-68 PSMA examination, one of the most recent studies included 319 patients with prostate carcinoma showed sensitivity of 77%, specificity of 100%, PPV of 100% and NPV of 91.4 on lesion based analysis (Oromieh et al, 2015). It was concluded that PSMA PET CT has the advantage of detecting lymph node involvement whether they are enlarged or not. All the 319 patient have performed diagnostic CT using IV contrast after injecting the Ga-68 PSMA and before acquiring the PET CT images.
For more information or to make a booking, please call our friendly staff at Lake Imaging St John of God Ballarat on (03) 5304 9000.